TODAY’S PATENT – MODIFIED HUMAN GROWTH HOROMONE POLYPEPTIDES AND THEIR USES

The said invention with the Patent Number US7939496B2 was registered in USPTO on May 10th, 2011.

This invention revolves around a modified growth hormone polypeptide and its potential uses. Growth hormone (GH) is a naturally occurring hormone produced by the pituitary gland that plays a crucial role in regulating growth, metabolism, and various physiological processes in the body. The modified growth hormone polypeptide described in this invention likely refers to a version of GH that has been altered or engineered to enhance its therapeutic properties or improve its stability, bioavailability, or other desirable characteristics.

The invention also encompasses the potential uses of this modified growth hormone polypeptide. These uses could span a wide range of applications in medicine, biotechnology, and agriculture. In the medical field, the modified growth hormone polypeptide may be developed as a therapeutic agent for treating growth disorders, hormone deficiencies, or other conditions where enhancing growth hormone activity is beneficial. It could also be explored for its potential in regenerative medicine, wound healing, or tissue repair.